Episode 1 - Aggregation play for pharmaceutical companies by Vaibhav Manek: Recent Episodes
KNAV
Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.
This podcast deals with potential tax benefit brought about by the recently enacted High Tax Exception (HTE) under Global Intangible Low Tax Income, commonly referred to as GILTI. The GILTI provisions introduced by TCJA were unintentionally penalising US taxpayers with domestic losses but having profitable controlled foreign corporations in jurisdictions having tax rates higher than that of the US. The GILTI HTE has brought about some much-awaited relief for such taxpayers.
Vaibhav Manek, Partner – KNAV, comments on the fundraising environment for technology businesses and the nuances of tech scale up with capital.
Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.